Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO ...

Seeking to prevent the spread of HIV, Unitaid is providing $31 million to South Africa and Zambia in hopes of widening access ...

Taken as prescribed, PrEP — shorthand for preexposure prophylaxis — is 99% effective in protecting people against sexual ...

Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...

A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...

The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the Centers for Disease Control and Prevention (CDC), The Wall Street Journal ...

Dr Robert Mutumba, the head of the Aids Control Programme at the Ministry of Health, told Daily Monitor that Ugandans are ...

Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...